Nuo Therapeutics, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
OQB
Paul Anthony Jacobs has reported beneficial ownership of 6.6% of Nuo Therapeutics, Inc.'s common stock, including exercisable warrants.